HARBIN, China, March 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. (AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the Company has rescheduled its first-quarter fiscal-year 2011 earnings release and conference call for March 17. The release date had been previously scheduled for March 16, 2011.
The Company will release its fiscal first-quarter results on Thursday, March 17, 2011, before the market open. A conference call to discuss fiscal first-quarter earnings results will be held on March 17, 2011, at 9:00 a.m. EDT.
Joining Mr. Shaoming Li, China Botanic's Chairman and CEO, will be Mr. Guangtao Li, the Company's Vice President, and Mr. David Dong, the Company's CFO.
To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-394-2209. International callers should dial +1-706-758-1481. The conference ID number for the call is 50917605.
If you are unable to participate in the call at this time, a replay will be available on Thursday, March 17, 2011 at 10:00 am Eastern Daylight Time, through Thursday, March 31, 2011. To access the replay, dial 800-642-1687. International callers should dial +1 706-645-9291. The conference ID number for the replay is 50917605.
ABOUT CHINA BOTANIC PHARMACEUTICAL INC.
China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China.
CCG Investor Relations:
China Botanic Pharmaceutical Inc.
Mr. Mark Collinson, Partner
Ms. Portia Tan, IR Contact
Phone: +1-310-954-1343 (Los Angeles)
Mr. Crocker Coulson, President
Phone: +1-646-213-1915 (New York)
SOURCE China Botanic Pharmaceutical Inc.